Skip to main content

Table 2 Age at appearance of signs and start of different treatments

From: Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports

Patients Age Age at appearance of signs and start of different treatments
Case # 1 N.NE 47 days Signs appeared
52 days Came to hospital with DKA; treatment: low-dose insulin infusion, fluid therapy, then maintenance insulin therapy
58 days Glibenclamide
2.4 years Repaglinide
10 years Repaglinide; no adverse events
Case # 2 I.M. 3 months and 5 days Signs appeared
3 months and 15 days Came to hospital with DKA; low-dose insulin infusion, fluid therapy, then maintenance insulin therapy
3 months and 20 days Glibenclamide
4 months and 20 days Repaglinide
9 years Repaglinide; no adverse events
  1. DKA diabetic ketoacidosis